Monkeypox disease and pregnancy. Where are we today? A review of literature.
Paschalia Kopanou TaliakaAndreas G TsantesAikaterini KonstantinidiParaskevi LiakouEvangelia-Filothei TavoulariDaniele PiovaniStefanos BonovasNicoletta IacovidouArgirios E TsantesRozeta SokouPublished in: Journal of perinatology : official journal of the California Perinatal Association (2023)
Monkeypox has emerged as a significant human pathogen, posing severe risks in vulnerable populations. At present, there is not enough data available as to whether pregnant women are more vulnerable to monkeypox infection, or they suffer more severe symptoms, and studies on this issue as well as to the possible adverse effects on the developing fetus are limited. The aim of this review, was to bring together what is known so far about monkeypox virus transmission, the clinical course of the disease, and associated maternal-fetal outcomes. Furthermore, to summarize the current available recommendations on the prevention and management of monkeypox infection during pregnancy, in order to help obstetricians and neonatologists navigate through this new challenging area and provide the best available care to their patients.
Keyphrases
- pregnant women
- end stage renal disease
- pregnancy outcomes
- ejection fraction
- endothelial cells
- newly diagnosed
- early onset
- healthcare
- chronic kidney disease
- palliative care
- type diabetes
- prognostic factors
- emergency department
- quality improvement
- chronic pain
- depressive symptoms
- sleep quality
- physical activity
- patient reported
- adverse drug